Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(33%)
Results Posted
100%(1 trials)

Phase Distribution

Ph not_applicable
1
33%
Ph phase_2
2
67%

Phase Distribution

0

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
2(66.7%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Completed(1)
Other(1)

Detailed Status

Completed1
unknown1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 22 (66.7%)
N/A1 (33.3%)

Trials by Status

completed133%
unknown133%
active_not_recruiting133%

Recent Activity

1 active trials
Showing 3 of 3
completedphase_2

Dose Ranging Study of Carbidopa-levodopa

NCT03023059
active_not_recruitingphase_2

Project 1 Aim 2, Adaptations of the Brain in Chronic Pain With Opioid Exposure

NCT05463367
unknownnot_applicable

Improving Quality of Life in Early Parkinson's Disease

NCT04590612

Clinical Trials (3)

Showing 3 of 3 trials
NCT03023059Phase 2

Dose Ranging Study of Carbidopa-levodopa

Completed
NCT05463367Phase 2

Project 1 Aim 2, Adaptations of the Brain in Chronic Pain With Opioid Exposure

Active Not Recruiting
NCT04590612Not Applicable

Improving Quality of Life in Early Parkinson's Disease

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3